Original Articles and Brief Reports

Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients

University of Southern California, USA
Mayo Clinic Arizona, USA
Karolinska Institute, Sweden
Guys and St. Thomas' Hospital, UK
Guys and St. Thomas' Hospital, UK
NU Hospital Organization
Mount Sinai School of Medicine, USA
Ospedali Riuniti di Bergamo, Italy and
Ospedali Riuniti di Bergamo, Italy and
Guys and St. Thomas' Hospital, UK
Mayo Clinic Arizona, USA
Mayo Clinic Arizona, USA
Hopital Saint-Louis, France
University of Southern California, USA
Mayo Clinic Arizona, USA
Vol. 97 No. 10 (2012): October, 2012 https://doi.org/10.3324/haematol.2011.061390